MedTrace Logo

Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery

NCT00704418 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2013-01-18

Study results available
· View outcomes & findings →

Summary

Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery

Conditions

  • Cataract

Interventions

DRUG

Bromfenac

sterile ophthalmic solution

DRUG

Placebo

sterile ophthalmic solution

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-01-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00704418 on ClinicalTrials.gov